| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | 0.21 | 0.1 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.077 | 0.1 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.1 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | -0.19 | 0.1 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |